Clinical Trials Logo

Clinical Trial Summary

As part of UCLA Health's commitment to developing a premier integrated health system built on a foundation of physician-led, team-based primary care, the Department of Medicine (DOM) recently implemented a new performance based incentive plan called the Primary Care Clinical Excellence (PCCE) Incentive Plan. This incentive plan was developed to motivate providers to improve health maintenance screening rates. The UCLA Health DOM Quality team is leading the implementation and evaluation of this new incentive plan across our primary care network. In addition, the DOM Quality team has partnered with the UCLA Anderson School of Management to study the most efficacious ways to frame and communicate performance based incentives. Understanding the factors that motivate physicians to deliver the highest quality primary care will provide pivotal insights into the successful implementation of performance based programs nationwide. The investigators believe that physicians who receive communication built on behavioral principles will demonstrate more motivation towards and success at meeting national primary care screening guidelines.


Clinical Trial Description

Currently, UCLA Health has 42 primary care clinics staffed with approximately 205 PCP's serving more than 300,000 patients. In order to improve health maintenance screening rates associated with the performance based program, the investigators will use a communication strategy that leverages behavioral principles to motivate providers to improve health maintenance screening rates. The investigators will implement a three-arm experimental communication campaign that includes monthly messages. The communication strategy will utilize behavioral change theory (particularly social comparison and recognition) to improve physician performance in health maintenance quality metrics. This study will primarily focus on one quality domain of the PCCE incentive program-Clinical Quality. Two further quality domains of the PCCE incentive program will serve as exploratory measures: Patient Experience and Professional Participation. For the primary outcome measure and high-priority secondary outcome measures, the investigators will first evaluate whether the combination of arms 2 and 3 differs from arm 1 in terms of the measures listed in the Outcome Measures section. If this comparison is statistically significant, the investigators will next compare arms 1 vs 2. and then, if also significant, the investigators will compare arms 1 vs 3 and 2 vs 3. For the 1 vs 3 and 2 vs 3 comparisons, we will use a Holm-Bonferroni p-value correction. These comparisons of treatment arms will be performed at the patient level using a mixed effects regression model, including random physician and clinic effects to account for clustering of patients. Control variables include (1) patient baseline order rates (or completion rates depending on the outcome measure) in July-October 2019, (2) patient characteristics (age, gender, comorbidity, insurance plan, zip code), and (3) physician characteristics (gender, race, years practiced, years at UCLA Health). Unless otherwise specified, p-values less than 0.05 will be considered statistically significant. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04237883
Study type Interventional
Source University of California, Los Angeles
Contact
Status Completed
Phase N/A
Start date November 1, 2019
Completion date January 1, 2021

See also
  Status Clinical Trial Phase
Completed NCT05594446 - Morphometric Study of the Legs and Feet of Diabetic Patients in Order to Collect Data Intended to be Used to Measure by Dynamometry the Pressures Exerted by Several Medical Compression Socks at the Level of the Forefoot
Completed NCT03975309 - DHS MIND Metabolomics
Completed NCT01855399 - Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes N/A
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Recruiting NCT04984226 - Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD Phase 2
Recruiting NCT05007990 - Caregiving Networks Across Disease Context and the Life Course
Active, not recruiting NCT04420936 - Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program N/A
Recruiting NCT03549559 - Imaging Histone Deacetylase in the Heart N/A
Completed NCT04903496 - Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database
Completed NCT01437592 - Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects Phase 1
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT03390179 - Hyperglycemic Response and Steroid Administration After Surgery (DexGlySurgery)
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Recruiting NCT05294822 - Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes N/A
Completed NCT04427982 - Dance and Diabetes/Prediabetes Self-Management N/A
Completed NCT02356848 - STEP UP to Avert Amputation in Diabetes N/A
Completed NCT03292185 - A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects Phase 1
Active, not recruiting NCT05477368 - Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes N/A
Completed NCT04496401 - PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus Phase 4